Food News and Research

RSS

Modest weight reduction reverses immune cell damage in obese people with diabetes

Australian scientists have shown for the first time that even modest weight loss reverses many of the damaging changes often seen in the immune cells of obese people, particularly those with Type 2 diabetes.

21 Apr 2010

Study shows Inuit children are tall as U.S. counterparts, but are also heavier

Inuit preschoolers in Nunavut are as tall as their U.S. counterparts but they're also heavier, according to a new study published in the online edition of the International Journal of Circumpolar Health.

21 Apr 2010

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.

21 Apr 2010

U.S. military will end formal operations in Haiti by June, official says

The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.

21 Apr 2010

Henry Ford Health System President to discuss practical strategies for success at educational symposium

A two-day educational symposium, "Going Radical: Creating the Hospital of the Future," may hold the key to revitalization. It will be held May 25 - 27.

21 Apr 2010

Nutrition experts call for sodium reduction strategies

Responding to the health threat posed by Americans' over-consumption of sodium, experts in the department of nutrition at Harvard School of Public Health (HSPH) and The Culinary Institute of America (CIA) called today for sodium reduction strategies that are strong and effective-and that maximize the enjoyment people derive from food.

21 Apr 2010

Systems biologists integrate new genetic framework to help predict adverse drug reactions

In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.

21 Apr 2010

Proteus Biomedical's wireless personal health device receives FDA marketing clearance

Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that it has received 510(k) clearance from the US Food and Drug Administration to market its wireless personal health device, the Raisin Personal Monitor.

21 Apr 2010

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China reported that its asthma drug Laevo-Bambutero will receive the China's State Food & Drug Administration's (SFDA) Fast Track Approval to enter clinical trials. The SFDA's Drug Review and Evaluation Center told the Company during recent consultations at the end of the Company's IND that formal approval would be granted by the Beijing office of the SFDA.

21 Apr 2010

Reuters examines uneven economic growth, welfare programs in India

Reuters reports on the recent efforts by India's government to expand welfare programs throughout the country: "Since helping the Congress party win re-election last year, welfare has fast become the government's knee-jerk answer to policy dilemmas as it tries to ease food inflation, help growth trickle down to the poor, and win hearts and minds in" the country, the news service writes.

21 Apr 2010

Higher consumption of added sugars in processed foods associated with lower levels of HDL-C: Study

Consuming a higher amount of added sugars in processed or prepared foods is associated with lower levels of high-density lipoprotein cholesterol and higher levels of triglycerides, which are important risk factors for cardiovascular disease, according to a study in the April 21 issue of JAMA.

21 Apr 2010

Elan's first-quarter total revenue up by 27% to $310.5M

Elan Corporation, plc, today reported its first quarter 2010 financial results.

21 Apr 2010

More testimony on Patel trial

In the ongoing trial of Dr. Jayant Patel for manslaughter of three men and grievous injury to the fourth during his tenure as Director of surgery at Bundaberg base hospital new testimony has surfaced. Patel had pleaded not guilty.

21 Apr 2010

FDA files consent decree against STERIS

The U.S. Food and Drug Administration today announced that a consent decree has been filed against the device manufacturer, STERIS Corp. of Mentor, Ohio. The decree stops the company from distributing unapproved and misbranded devices used to sterilize heat-sensitive instruments and medical devices. It prohibits the distribution of the STERIS System 1 Processor, or SS1, a tabletop liquid chemical system marketed to disinfect certain devices, such as endoscopes, that cannot withstand steam sterilization.

21 Apr 2010

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced study results today that demonstrate a regimen of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with bevacizumab (Avastin®) may have potential in the treatment of triple-negative breast cancers.

21 Apr 2010

FDA provides guidance to help caregivers, patients safely use complex medical devices in home

The U.S. Food and Drug Administration today announced a new initiative to ensure that caregivers and patients safely use complex medical devices in the home.

21 Apr 2010

Prevention is key to minimize choking hazards among young children

Though airway obstructions in young children occur less often than other types of injuries, the death rate is higher, according to new research from Children's National Medical Center.

21 Apr 2010

Stemedica receives FDA IND approval for ischemic stroke clinical trial using allogeneic stem cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).

21 Apr 2010

FDA eyes home-based medical equipment for regulation

"With hospitals discharging patients after ever-shorter stays, more people are recovering and continuing post-operative care, or treating chronic conditions, with sophisticated medical equipment at home," The Wall Street Journal reports.

21 Apr 2010

FDA approves Lupin Pharmaceuticals' Imipramine Pamoate capsules

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Imipramine Pamoate capsules, 75 mg, 100 mg, 125 mg and 150 mg strengths. Commercial shipments of the product have already commenced.

21 Apr 2010

Food News and Research

Modest weight reduction reverses immune cell damage in obese people with diabetes

Study shows Inuit children are tall as U.S. counterparts, but are also heavier

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

U.S. military will end formal operations in Haiti by June, official says

Henry Ford Health System President to discuss practical strategies for success at educational symposium

Nutrition experts call for sodium reduction strategies

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Proteus Biomedical's wireless personal health device receives FDA marketing clearance

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Reuters examines uneven economic growth, welfare programs in India

Higher consumption of added sugars in processed foods associated with lower levels of HDL-C: Study

Elan's first-quarter total revenue up by 27% to $310.5M

More testimony on Patel trial

FDA files consent decree against STERIS

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

FDA provides guidance to help caregivers, patients safely use complex medical devices in home

Prevention is key to minimize choking hazards among young children

Stemedica receives FDA IND approval for ischemic stroke clinical trial using allogeneic stem cells

FDA eyes home-based medical equipment for regulation

FDA approves Lupin Pharmaceuticals' Imipramine Pamoate capsules

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News